Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02350595
Other study ID # FISK2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2011
Est. completion date December 2012

Study information

Verified date December 2021
Source University of Bergen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The potential health effects of high intake of lean or fatty fish will be investigated in overweight or obese adults. Participants consume 750g/week of fillets of fish for 8 weeks. Hypothesis: High intake of fatty or lean fish will beneficially affect glucose regulation and the immune system.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - BMI =27 kg/m2 - fasting blood glucose =7.0 mmol/L Exclusion Criteria: - pregnancy - incompatibility with fish consumption (allergies, intolerance and/or dislike) - diagnosed diabetes mellitus, heart disease or gastrointestinal diseases - use of medications affecting lipid metabolism or glucose homeostasis - use of anti-inflammatory medications - use of supplements containing long chain n-3 fatty acids - intentional weight loss - and large fluctuation in body weight (>3 kg) over the previous two months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Lean fish

Fatty fish


Locations

Country Name City State
Norway Haukeland University Hospital Bergen

Sponsors (4)

Lead Sponsor Collaborator
University of Bergen Bergen Medical Research Foundation, Leroy Seafood Group ASA, Skretting ASA

Country where clinical trial is conducted

Norway, 

References & Publications (5)

Bratlie M, Hagen IV, Helland A, Erchinger F, Midttun Ø, Ueland PM, Rosenlund G, Sveier H, Mellgren G, Hausken T, Gudbrandsen OA. Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile a — View Citation

Bratlie M, Hagen IV, Helland A, Midttun Ø, Ulvik A, Rosenlund G, Sveier H, Mellgren G, Ueland PM, Gudbrandsen OA. Five salmon dinners per week were not sufficient to prevent the reduction in serum vitamin D in autumn at 60° north latitude: a randomised tr — View Citation

Hagen IV, Helland A, Bratlie M, Midttun Ø, McCann A, Sveier H, Rosenlund G, Mellgren G, Ueland PM, Gudbrandsen OA. TMAO, creatine and 1-methylhistidine in serum and urine are potential biomarkers of cod and salmon intake: a randomised clinical trial in ad — View Citation

Helland A, Bratlie M, Hagen IV, Midttun Ø, Sveier H, Mellgren G, Ueland PM, Gudbrandsen OA. Effect of high intake of cod or salmon on serum total neopterin concentration: a randomised clinical trial. Eur J Nutr. 2021 Sep;60(6):3237-3248. doi: 10.1007/s003 — View Citation

Helland A, Bratlie M, Hagen IV, Mjøs SA, Sørnes S, Ingvar Halstensen A, Brokstad KA, Sveier H, Rosenlund G, Mellgren G, Gudbrandsen OA. High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA co — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in serum concentrations of glucose baseline and 8 weeks
Secondary Changes in insulin, insulin C-peptide, leukocyte fatty acids, leukocyte function, body weight and composition, and intake of energy and macronutrients within the groups over time. baseline and 8 weeks
Secondary Changes in serum vitamin concentrations after fish intake. Serum concentrations of fat-soluble and water-soluble vitamins were measured, and dietary intakes of vitamins were estimated based on reported food intake from 5-day food diaries. baseline and 8 weeks
Secondary Changes in serum and urine concentrations of amino acids and metabolites of amino acids after fish intake. Concentrations of amino acids and amino acid metabolites were measured in fasting serum and morning urine baseline and 8 weeks
Secondary Changes in fecal microbiota profile after fish intake. 54 DNA bacterial markers targeting more than 300 bacteria based on their 16S rRNA sequence in seven variable regions were analysed in feces (72h collection) baseline and 8 weeks
Secondary Changes in fecal and serum concentrations of lipids and bile acids after fish intake. Fat, cholesterol and total bile acids were quantified in feces (72h collection) and fasting serum. baseline and 8 weeks
Secondary Changes in markers of oxidative stress after fish intake. Antioxidant enzymes, antioxidant enzyme cofactors and biomarkers of oxidative stress were quantified in serum baseline and 8 weeks
Secondary Changes in total neopterin after fish intake Total neopterin was measured in serum. baseline and 8 weeks
Secondary Quantification of markers of kidney dysfunction Urine concentrations of cystatin C and T-cell immunoglobulin mucin-1 (relative to creatinine) were measured as markers of kidney function baseline and 8 weeks
Secondary Changes in amino acids and metabolites of amino acids after a standardized meal. Concentrations of amino acids and amino acid metabolites were measured in fasting and postprandial serum baseline
Secondary Changes in metabolites and co-factors involved in one-carbon metabolism after a standardized meal Concentrations of relevant metabolites and co-factors were measured in fasting and postprandial serum baseline
Secondary Comparisons of amino acid concentrations in serum and urine between men and women Concentrations of amino acids and amino acid metabolites were measured in serum and urine baseline
Secondary Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine between men and women Concentrations of relevant metabolites and co-factors were measured in serum and urine baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2